Allergy Therapeutics (AGY.LSE) Q4 2024 Earnings

6NovConfirmed
Q2 2023
Q1 2024
Q1 2024
Q4 2024
-0.59
-0.39
-0.2
0

Details

Expected EPS
-0.5052658634399999
Actual EPS
N/A
Surprise EPS
0.51
Surprise Percent
+100%

Description

Allergy Therapeutics (AGY.LSE) will report earnings of for Q4 2024 on November 06, 2024.

0 Comments

Share your thoughts